What adjuvant treatment approach would you choose for a premenopausal woman with lymph node positive poorly differentiated metaplastic breast cancer that is ER low+, PR+, HER2 negative?   

Is there a role for KEYNOTE-522 since ER + metaplastic breast cancer have similar behavior to triple negative metaplastic breast cancer? 

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Geisinger Medical Center
Thanks for commenting. What if the tumor on biopsy...
Medical Oncologist at Harvard Medical School
Oops, sorry, I missed that you are treating this i...
Sign in or Register to read more